Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.52 |
| ▸ | STAT3 | P40763 | 12/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Shanzhiside Methyl Ester SCHEMBL12207355 | 0.90 | POLB (0.62) | MAPTPOLBCTDSP1STAT3MEN1 | |
| Shanzhiside Methyl Ester SCHEMBL29965826 | 0.90 | POLB (0.62) | MAPTPOLBCTDSP1STAT3MEN1 | |
| Shanzhiside Methyl Ester SCHEMBL28007134 | 0.90 | POLB (0.62) | MAPTPOLBCTDSP1STAT3MEN1 | |
| SCHEMBL29425733 | 0.85 | MAPT (0.56) | MAPTPOLBCTDSP1STAT3MEN1 | |
| SCHEMBL2636258 | 0.82 | MAPT (0.61) | MAPTPOLBCTDSP1STAT3MEN1 | |
| SCHEMBL29426237 | 0.80 | MAPT (0.63) | MAPTPOLBCTDSP1STAT3MEN1 | |
| Barlerin SCHEMBL3244727 | 0.78 | POLB (0.56) | MAPTPOLBCTDSP1STAT3MEN1 | |
| Barlerin SCHEMBL29425807 | 0.78 | POLB (0.56) | MAPTPOLBCTDSP1STAT3MEN1 | |
| SCHEMBL29354606 | 0.76 | HSP90AA1 (0.52) | MAPTPOLBCTDSP1MEN1KMT2A | |
| SCHEMBL4604126 | 0.76 | HSP90AA1 (0.52) | MAPTPOLBCTDSP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117427088-B | Equivalent component group of Angong bezoar bolus for improving ischemic cerebral apoplexy injury and application thereof | 中国药科大学 | 2025-05-09 | — | — | CN | claimed |
| CN-119915925-A | Method for detecting characteristic spectrum of compound cape jasmine root granule, standard characteristic spectrum of compound cape jasmine root granule and application | 厦门市中医院(北京中医药大学东直门医院厦门医院、厦门市华侨医院、厦门市中西医结合肝病研究所、厦门国际中医培训交流中心) | 2025-05-02 | — | — | CN | claimed |
| CN-114362011-B | Electric cabinet with external control assembly | 中研科学研究院(南安)有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-118549567-B | Method for determining component content in gardenia medicinal material | 湖北中医药大学 | 2024-10-22 | — | — | CN | claimed |
| CN-118806779-A | Pharmaceutical composition and preparation method and application thereof | 陕西盘龙药业集团股份有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118549567-A | Method for determining component content in gardenia medicinal material | 湖北中医药大学 | 2024-08-27 | — | — | CN | claimed |
| CN-118501286-A | Detection method of traditional Chinese medicine composition | 江苏康缘药业股份有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-115494168-B | Method for measuring content of multiple components of Sang Xingshang | 神威药业集团有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116124945-B | A method for analyzing and identifying chemical components in traditional Chinese medicine preparations based on UPLC-Q-TOF-MS technology | 广州白云山明兴制药有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117427038-A | Gardenia jasminoides ellis fermented soybean soup aqueous extract, particles, application and preparation method thereof | 中国人民解放军海军军医大学 | 2024-01-23 | — | — | CN | claimed |
| CN-109464514-A | A kind of capejasmine extract that treating hyperbileacidemia and its preparation and application | 中国中医科学院中药研究所 | 2019-03-15 | — | — | CN | claimed |
| EP-2370072-B1 | PHYTOESTROGENIC COMPOSITIONS FOR PREVENTING OR TREATING SYMPTOMS ASSOCIATED WITH MENOPAUSE | NATURAL ENDOTECH CO LTD (KR) | 2017-06-28 | — | — | EP | claimed |
| US-9433595-B2 | Phytoestrogenic compositions for preventing or treating symptoms associated with menopause | NATURAL ENDOTECH CO., LTD. (KR) | 2016-09-06 | — | — | US | claimed |
| CN-103435664-A | Preparation method for gardenia jasminoides gardenoside B | NANJING BIAOKE BIO TECHNOLOGY CO LTD | 2013-12-11 | — | — | CN | claimed |
| US-20110251145-A1 | Phytoestrogenic Compositions for Preventing or Treating Symptoms Associated with Menopause | NATURAL ENDOTECH CO., LTD. (KR) | 2011-10-13 | — | — | US | claimed |
| EP-2370072-A1 | PHYTOESTROGENIC COMPOSITIONS FOR PREVENTING OR TREATING SYMPTOMS ASSOCIATED WITH MENOPAUSE | Natural Endotech Co., Ltd. (KR) | 2011-10-05 | — | — | EP | claimed |
| WO-2010074361-A1 | PHYTOESTROGENIC COMPOSITIONS FOR PREVENTING OR TREATING SYMPTOMS ASSOCIATED WITH MENOPAUSE | NATURAL ENDOTECH CO., LTD. (KR) | 2010-07-01 | — | — | WO | claimed |
| CN-101002791-B | Traditional Chinese medicine composition for treating cerebrovascular disease, and its preparing method | CHUANLIANG HU | 2010-04-07 | — | — | CN | claimed |
| CN-101113156-A | Method for preparing cape jasmine glycosides standard substance and its analogue | RENBING SHI (CN) | 2008-01-30 | — | — | CN | claimed |
| CN-101002791-A | Traditional Chinese medicine composition for treating cerebrovascular disease, and its preparing method | HU CHUANLIANG (CN) | 2007-07-25 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251145-A1 | Phytoestrogenic Compositions for Preventing or Treating Symptoms Associated with Menopause | ESR1, CYP19A1, GPER1 | MAPT 3922/4885POLB 4808/4885CTDSP1 4788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.